Navigation Links
BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies Will Come Together
Date:9/23/2010

BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies... -- MADRID, September 23, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies Will Come Together

 

MADRID, September 23, 2010 /PRNewswire/ -- BioSpain 2010 will host 2,000 business meetings, 135% more than the previous event, between more than 600 companies, 25% of which are not Spanish. This percentage includes 150 foreign companies and institutions, which have decided to come to Spain to find new business opportunities within the biotechnology sector. This figure has increased by 60% as compared to the number of foreign companies that attended BioSpain 2008.

These figures turn BioSpain into the most important biotechnology-related event held by a Southern European country and it has also become a pioneer in Spain regarding the introduction of the partnering system whereby bilateral meetings between companies are fostered.

Pamplona will be the host city for this fifth BioSpain event (http://www.biospain2010.org) to be held from September 29th to October 1st. This biannual event is organised by the Spanish Association of Biocompanies (ASEBIO) and on this occasion it also has the collaboration of the Navarre Government, through the Navarre Development Association (SODENA) with a view to disseminating biotechnological knowledge in Spain and contributing to its development. In turn, the event will be officially sponsored by companies as prestigious as Merck, Zeltia, AB BIOTICS, Genetrix, Genoma Espana, Caja Navarra and ICEX. The event is expected to be attended by more than 1,200 participants.

BioSpain 2010 will have 132 stands in the commercial exhibition, 15% more than on the previous event. These stands will provide room for 160 companies, 24% of which are not Spanish (38), which once again underlines the international spirit of this event as one of its highlights.

Furthermore, BioSpain 2010 will be honoured with the presence of three internationally acknowledged lecturers, such as Carlos Cordon-Cardo, Deputy Director of the Department of Pathology of Columbia University; Larry Fritz, CEO of Covella Pharmaceuticals and partner of the venture capital firm Westfield Capital Management, and Conny Bogentoft, CEO of Karolinska Development AB. Cordon-Cardo will explain the role of tumour stem cells; Larry Fritz will lecture on how to create and develop a successful biotechnology company and Bogentoft will explain how to materialise technological transfer, in other words, how to turn an idea into a business activity.

For additional information: Lucia Cecilia Mercado ASEBIO Communication Manager Phone No.: +34-91-210-93-74 Mobile: +34-663-117-293 lcecilia@asebio.com Berbes Asociados Maribel Otero/Jorge Sanchez Phone No.: +34-91-563-23-00 maribelotero@berbes.com jorgesanchez@berbes.com
'/>"/>

SOURCE Asebio
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FOX Business Network Airing In-Depth Look at NeoStem
2. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
3. Executive Mindshare Announces New Social Media Platform for Vertical Business Networks
4. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
5. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
6. Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio
7. Bilcare AG to Acquire INEOS Global Films Business for EUR100 Million
8. Orchestrall Sponsors China Business Toolbox: Brings Focus to the How and When of China Market Access
9. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
10. THE PLANNING SHOP international Announces Oncology Business Unit
11. Sirius Genomics Announces Appointment of Senior Director of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex Biosciences ... fully automated benchtop system for collecting intact circulating tumor cells (CTCs) that are ... Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). , ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells ... multiple areas of medicine, due to their differentiating characteristics. Stem cells are unique as ... ability to be induced to become tissue or organic-specific cells with special functions. ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... and manufacturing solutions for original equipment manufacturers (OEMs) , today announced it has ... Technologies’ third consecutive year winning in its category of electronics manufacturing services (EMS) ...
(Date:2/21/2017)... 2017   Logicalis Healthcare Solutions , the healthcare-focused ... managed services provider ( www.us.logicalis.com ), today announced a ... The new service will help hospital CIOs make the ... physicians, nurses and other clinicians immediate access to a ... will allow hospital IT staff to focus on broader ...
Breaking Biology Technology:
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
(Date:1/24/2017)... NEW YORK , Jan. 24, 2017 /PRNewswire/ ... market study of the laboratory use of nuclear ... of 363 experienced end-users and profiled current practices, ... three years, as well as growth and opportunities. ... NMR, Instrument suppliers, NMR instruments, needs and innovation ...
Breaking Biology News(10 mins):